Sterile Filtration Market Size (2024 - 2029)

Sterile Filtration Market Analysis

The sterile filtration market is expected to register a CAGR of 8% over the forecast period.

The global spread of COVID-19 had a significant impact on the market because sterilization or filtration is critical for the removal of microbes, such as bacteria, fungi, viruses, and protozoa, that may contaminate medicinal drugs, vaccines, or alternative substances, chemicals, food, and other products, posing health risks. The growing demand for COVID-19 vaccines and treatment medications propelled the sterile filtration market during the pandemic. According to an article published in the Computational and Structural Biotechnology Journal in May 2021, there were 184 vaccine candidates in preclinical research and 88 under clinical trials. The sterile filtering method is an important step in the aseptic process for recovering COVID-19 vaccine candidates since it supports high selectivity and effective vaccine candidates. Thus, COVID-19 enhanced the demand for sterile filtration techniques and is expected to follow the same trend over the forecast period, as sterile filtration is one of the important procedures in drug formulation development.

The market is driven by the rising prevalence of chronic diseases and the the growing pharmaceutical and biopharmaceutical industries. Chronic diseases include cancer, cardiovascular, neurological and others diseases, and are expected to propel the growth of the market. According to the American Cancer Society's 2021 report, about 1.9 million cancer cases (970,250 in males and 927,910 in females) were diagnosed in 2021 in the United States, and 608,570 Americans died from it. Thus, the high burden of chronic diseases and high investments in life science research and development are expected to drive market growth.

With increasing expenditures by biotechnology and pharmaceutical businesses in expanding their product lines and geographical reach in single-use technologies, the need for sterile filtration is predicted to increase, bolstering the growth of the analyzed market. For instance, in July 2021, Cytiva and Pall Corporation revealed a USD 1.5 billion investment over the next two years to meet the rising demand for biotechnology solutions, with over USD 300 millionallocated for single-use technologies, such as bioreactor and single-use filters, to expand operations in the United States and the United Kingdom.

Thus, all the above-mentioned factors are expected to boost the market over the forecast period. However, the high cost of sterile filtration may restrain market growth.

Sterile Filtration Industry Segmentation

As per the scope of the report, sterile filtration is a technique used in manufacturing drugs to avoid contamination by filtering the micro-organisms without degrading product quality. The sterile filtration market is segmented by product (cartridge filter, capsule filter, syringe filter, other membrane filters, accessories), end user (pharmaceutical and biopharmaceutical companies, contract research organizations, research laboratories), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions. The report offers the value of market sizes and forecasts in USD million for the above segments.